Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Daniel

Showing results (421-430 of 445) with videos related to

Pageof 45
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 18, 2023
Weight of evidence for cross-species conservation of androgen receptor-based biological activitySara M F Vliet, Kristan J Markey, Scott G Lynn, et al.
Neuro-Oncology|July 3, 2021
Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patientsEmily J Tonogai, Shan Huang, Rachel C Botham, et al.
Scientific Reports|March 24, 2026
The first limb-sparing use of histotripsy for canine osteosarcomaElliana R Vickers, Lauren N Ruger, Alayna N Hay, et al.
Regulatory Toxicology and Pharmacology : RTP|March 9, 2018
International regulatory requirements for skin sensitization testingAmber B Daniel, Judy Strickland, David Allen, et al.
Regulatory Toxicology and Pharmacology : RTP|May 13, 2019
Exploring current read-across applications and needs among selected U.S. Federal AgenciesGrace Patlewicz, Lucina E Lizarraga, Diego Rua, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 1, 2026
Durvalumab Consolidation in Limited-Stage SCLC: Outcomes by Prior Concurrent Chemoradiotherapy and Prophylactic Cranial Irradiation in the Phase 3 ADRIATIC TrialSuresh Senan, Byoung Chul Cho, Konstantin K Laktionov, et al.
American Journal of Human Genetics|October 25, 2011
Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acidKathrin Laue, Hans-Martin Pogoda, Philip B Daniel, et al.
Mucosal Immunology|October 4, 2018
CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cellsT G Moreira, L S Horta, A C Gomes-Santos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2019
Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153)David R Spigel, Michael McCleod, Robert M Jotte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancerDavid R Spigel, Thomas J Ervin, Rodryg A Ramlau, et al.
Pageof 45

Showing results (421-430 of 445) with videos related to

Sort By:
Pageof 45
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 18, 2023
Weight of evidence for cross-species conservation of androgen receptor-based biological activitySara M F Vliet, Kristan J Markey, Scott G Lynn, et al.
Neuro-Oncology|July 3, 2021
Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patientsEmily J Tonogai, Shan Huang, Rachel C Botham, et al.
Scientific Reports|March 24, 2026
The first limb-sparing use of histotripsy for canine osteosarcomaElliana R Vickers, Lauren N Ruger, Alayna N Hay, et al.
Regulatory Toxicology and Pharmacology : RTP|March 9, 2018
International regulatory requirements for skin sensitization testingAmber B Daniel, Judy Strickland, David Allen, et al.
Regulatory Toxicology and Pharmacology : RTP|May 13, 2019
Exploring current read-across applications and needs among selected U.S. Federal AgenciesGrace Patlewicz, Lucina E Lizarraga, Diego Rua, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 1, 2026
Durvalumab Consolidation in Limited-Stage SCLC: Outcomes by Prior Concurrent Chemoradiotherapy and Prophylactic Cranial Irradiation in the Phase 3 ADRIATIC TrialSuresh Senan, Byoung Chul Cho, Konstantin K Laktionov, et al.
American Journal of Human Genetics|October 25, 2011
Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acidKathrin Laue, Hans-Martin Pogoda, Philip B Daniel, et al.
Mucosal Immunology|October 4, 2018
CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cellsT G Moreira, L S Horta, A C Gomes-Santos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2019
Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153)David R Spigel, Michael McCleod, Robert M Jotte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancerDavid R Spigel, Thomas J Ervin, Rodryg A Ramlau, et al.
Pageof 45